India, June 19 -- Jubilant Pharmova announced that the US Food and Drug Administration (USFDA) has completed an inspection of the contract manufacturing facility of its subsidiary, Jubilant HollisterStier LLC (JHS), located in Spokane, Washington, USA, on June 17, 2026.
Following the inspection, the USFDA issued eight observations. The company clarified that none of the observations are related to sterility assurance concerns.
JHS plans to submit its response to the observations within 15 business days and has reiterated its commitment to addressing all findings comprehensively.
Jubilant HollisterStier LLC operates under Jubilant Pharma Holding Inc., which is a subsidiary of Jubilant Pharma Limited, Singapore, a wholly owned subsidiary o...